JP2017537106A5 - - Google Patents

Download PDF

Info

Publication number
JP2017537106A5
JP2017537106A5 JP2017528970A JP2017528970A JP2017537106A5 JP 2017537106 A5 JP2017537106 A5 JP 2017537106A5 JP 2017528970 A JP2017528970 A JP 2017528970A JP 2017528970 A JP2017528970 A JP 2017528970A JP 2017537106 A5 JP2017537106 A5 JP 2017537106A5
Authority
JP
Japan
Prior art keywords
vaccine
antigen
adjuvant composition
composition according
polymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017528970A
Other languages
English (en)
Japanese (ja)
Other versions
JP6802790B2 (ja
JP2017537106A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/062836 external-priority patent/WO2016086222A1/en
Publication of JP2017537106A publication Critical patent/JP2017537106A/ja
Publication of JP2017537106A5 publication Critical patent/JP2017537106A5/ja
Application granted granted Critical
Publication of JP6802790B2 publication Critical patent/JP6802790B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017528970A 2014-11-26 2015-11-27 アジュバント組成物及び関連方法 Active JP6802790B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201462084698P 2014-11-26 2014-11-26
US62/084,698 2014-11-26
US201562137659P 2015-03-24 2015-03-24
US62/137,659 2015-03-24
PCT/US2015/062836 WO2016086222A1 (en) 2014-11-26 2015-11-27 Adjuvant compositions and related methods

Publications (3)

Publication Number Publication Date
JP2017537106A JP2017537106A (ja) 2017-12-14
JP2017537106A5 true JP2017537106A5 (https=) 2018-11-29
JP6802790B2 JP6802790B2 (ja) 2020-12-23

Family

ID=56075072

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017528970A Active JP6802790B2 (ja) 2014-11-26 2015-11-27 アジュバント組成物及び関連方法

Country Status (9)

Country Link
EP (1) EP3223846B1 (https=)
JP (1) JP6802790B2 (https=)
AU (1) AU2015353376B2 (https=)
CA (1) CA2968389C (https=)
DK (1) DK3223846T3 (https=)
ES (1) ES2961965T3 (https=)
MX (1) MX388527B (https=)
PL (1) PL3223846T3 (https=)
WO (1) WO2016086222A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10195261B2 (en) 2014-11-26 2019-02-05 VaxLiant, LLC Adjuvant compositions and related methods
US9636397B2 (en) * 2015-03-24 2017-05-02 VaxLiant, LLC Adjuvant compositions and related methods
CA3106341A1 (en) 2018-07-13 2020-01-16 Biomune Company New vaccines against avian reoviruses
US12558414B2 (en) 2019-07-12 2026-02-24 Biomune Company Method for vaccinating avians against reovirus

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2909462A (en) 1955-12-08 1959-10-20 Bristol Myers Co Acrylic acid polymer laxative compositions
US5961970A (en) 1993-10-29 1999-10-05 Pharmos Corporation Submicron emulsions as vaccine adjuvants
US20080292663A1 (en) * 2007-05-22 2008-11-27 Gerber Jay D Adjuvant compositions and methods for delivering vaccines
MX2010014026A (es) * 2008-06-27 2011-02-15 Pfizer Composiciones adyuvantes novedosas.
CA2866170A1 (en) * 2012-03-12 2013-09-19 Advanced Bioadjuvants, Llc Adjuvant and vaccine compositions
WO2014071219A1 (en) * 2012-11-01 2014-05-08 Factor Bioscience Inc. Methods and products for expressing proteins in cells

Similar Documents

Publication Publication Date Title
Silveira et al. DNA vaccines against COVID-19: Perspectives and challenges
Dhama et al. DNA vaccines and their applications in veterinary practice: current perspectives
Ahmadivand et al. Oral DNA vaccines based on CS-TPP nanoparticles and alginate microparticles confer high protection against infectious pancreatic necrosis virus (IPNV) infection in trout
Kozak et al. The integrated consideration of vaccine platforms, adjuvants, and delivery routes for successful vaccine development
Shams Recent developments in veterinary vaccinology
Kembou-Ringert et al. Tilapia lake virus vaccine development: a review on the recent advances
Cao Adjuvants for foot-and-mouth disease virus vaccines: recent progress
Lofano et al. Technological approaches to streamline vaccination schedules, progressing towards single-dose vaccines
Diaz-San Segundo et al. Poly ICLC increases the potency of a replication-defective human adenovirus vectored foot-and-mouth disease vaccine
JP2017537106A5 (https=)
KB et al. Vaccine and vaccination as a part of human life: In view of COVID‐19
Simerska et al. Oral vaccine delivery-new strategies and technologies
Fowler et al. Progress in the development of DNA vaccines against foot-and-mouth disease
JP6484241B2 (ja) ＰＲＲＳおよびローソニア・イントラセルラリス（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）に対するブタワクチン
Xu et al. Evaluation of a chimeric multi-epitope-based DNA vaccine against subgroup J avian leukosis virus in chickens
Yan et al. Recombinant Saccharomyces cerevisiae serves as novel carrier for oral DNA vaccines in Carassius auratus
JP6802790B2 (ja) アジュバント組成物及び関連方法
JP5865350B2 (ja) 母系由来の抗体の存在下での投与に適したマイコプラズマ・ハイオニュ−モニエに対するワクチン
Sanicas et al. A review of COVID-19 vaccines in development: 6 months into the pandemic
Raviprakash et al. Needle-free injection of DNA vaccines: a brief overview and methodology
CN115996751A (zh) 与离子液体佐剂有关的方法和组合物
Kar et al. New developments in veterinary vaccines
Ahmed et al. Modern vaccine strategies for emerging zoonotic viruses
Sun et al. mRNA Vaccine Development for Emerging Animal and Zoonotic Diseases.
JP2013545733A (ja) ヒト免疫不全ウィルス（ｈｉｖ）の組換えエンベロープ蛋白質及びそれを含むワクチン